Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 2, 2005, Pages 143-151

  Wiley, Dorothy J ^a   Huh, John ^b   Rao, Jian Yu ^a   Chang, Christopher ^a   Goetz, Matthew ^c   Poulter, Melinda ^d   Masongsong, Emmanuel ^a   Chang, Ching I ^a   Bernard, Hans Ulrich ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Anal carcinoma; DNA methylation; Gene expression; HIV homosexual men; Latency; Papillomavirus; Progression

Indexed keywords

DINUCLEOTIDE; VIRUS DNA;

ANUS; ANUS DISEASE; ANUS TUMOR; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA METHYLATION; ENHANCER REGION; EPITHELIUM CELL; GENE MAPPING; GENETIC HETEROGENEITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; WART VIRUS; WART VIRUS 45;

ANAL CANAL; BASE SEQUENCE; BIOPSY; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; DNA PRIMERS; DNA, VIRAL; ENHANCER ELEMENTS (GENETICS); GENOME, VIRAL; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INTESTINAL MUCOSA; MALE; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 19644385121     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Melbye M, Biggar RJ. A profile of HIV-risk behaviours among travellers - a population based study of Danes visiting Greenland. Scand J Soc Med. 1994;22:204-208.
2. Melbye M, Frisch M, The role of human papillomaviruses in anogenital cancers. Semin Cancer Biol. 1998;8:307-313.
3. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317:973-977.
4. Melbye M, Cote TR, Kessler L, et al. High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet. 1994;343:636-639.
5. Frisch M, Biggar RJ, Goedert JJ, Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92:1500-1510.
6. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337:1350-1358.
7. Frisch M, Glimelius B, van den Brule AJ, et al. Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma. Br J Cancer. 1998;78:1534-1538.
8. Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ. 1993;306:419-422.
9. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 1989;49:4677-4681.
10. Palefsky JM, Holly EA, Ralston ML, et al. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 1998;12:495-503.
11. Xi LF, Critchlow CW, Wheeler CM, et al. Risk of anal carcinoma in situ in relation to human papillomavirus Type 16 variants. Cancer Res. 1998;58:3839-3844.
12. Munoz N, Bosch FX, de Sanjosé S, et al. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
13. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis, Cancer. 1995;76:1888-1901.
14. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.
15. de Sanjose S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res. 2002;89:201-211.
16. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy, Sex Transm Dis. 2004;31:96-99.
17. Bernard HU. Gene expression of genital human papillomaviruses and potential antiviral approaches. Antivir Ther. 2002;7:219-237.
18. Ai W, Toussaint E, Roman A. CCAAT displacement protein binds to and negatively regulates human papillomavirus type 6 E6, E7, and E1 promoters. J Virol. 1999;73:4220-4229.
19. Pater MM, Hughes G, Hyslop DE, et al. Glucocorticoid-dependent oncogcnic transformation by type 16 but not type 11 human papilloma virus DNA. Nature. 1988;335:832-835.
20. Chan WK, Klock G, Bernard HU. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol. 1989;63:3261-3269.
21. Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985;314:111-114.
22. Stünkel W, Huang Z, Tan SH, et al. Nuclear matrix, attachment regions of human papillomavirus-16 repress or activate the E6 promoter depending on the physical state of the viral DNA. J Virol. 2000;74:2489-2501.
23. Bhende PM, Seaman WT, Delecluse HJ, et al. The EBV lyti'c switch protein, Z, preferentially binds to and activates the methylated viral genome, Nat Genet. 2004;36:1099-1104.
24. Bird AP. The essentials of DNA methylation. Cell. 1992;70:5-8.
25. Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416:552-556.
26. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245-254.
27. Jones PA. Epigenetics in carcinogenesis and cancer prevention. Ann NY Acad Sci. 2003;983:213-219.
28. Sugawara K, Fujinaga K, Yamashita T, et al. Integration and methylation of shope papilloma virus DNA in the transplantable V×2 and V×7 rabbit carcinomas. Virology. 1983;131:88-99.
29. Wettstein FO, Stevens JG. Shope papilloma virus DNA is extensively methylated in non-virus-producing neoplasms. Virology. 1983;126:493-504.
30. Burnett TS, Sleeman P. Uneven distribution of methylation sites within the human papillomavirus la genome: possible relevance to viral gene expression. Nucleic Acids Res. 1984;12:8847-8860.
31. Rösl F, Arab A, Klevenz B, et al. The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol. 1993;74:791-801.
32. Badal V, Chuang LSH, Badal S, et al. CpG methylation of human papillomavirus-16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol. 2003;77:6227-6234.
33. Kim K, Gamer-Hamrick PA, Fisher C, et al. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol. 2003;77:12450-12459.
34. Badal S, Badal y Calleja-Macias IE, et al. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology. 2004;324:483-492.
35. Van Tine BA, Kappes JC, Banerjee NS, et al. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol. 2004;78:11172-11186.
36. Kalantari M, Calleja-Macias IE, Tewari D, et al. Conserved methylation patterns of human papillomavirus-16 DNA in asymptomatic infection and cervical neoplasia. J Virol. 2004;78:12762-12772.
37. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-361.
38. Gravitt PE, Peyton C, Wheeler C, et al. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods. 2003;112:23-33.
39. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA. 1992;89:1827-1831.
40. Farmer AD, Calef CE, Millman K, et al. The human papillomavirus database. J Biomed Sci. 1995;2:90-104. Available at: http://hpv-web.lanl.gov/stdgen/ virus/hpv/compendium/htdocs/.
41. SAS Institute, Inc. Proc GENMOD. In: SAS Statistics. Cary, NC: SAS Institute, Inc. 1999:1382-1464.
42. Stünkel W, Bernard HU The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol. 1999;73:1918-1930.
43. Vertino PM, Sekowski JA, Coll JM, et al. DNMTI is a component of a multiprotein DNA replication complex. Cell Cycle. 2002;1:416-423.
44. Daniel B, Mukherjee G, Seshadri L, et al. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J Gen Virol. 1995;76:2589-2593.
45. Thain A, Jenkins O, Clarke AR, et al. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences, J Virol. 1996;70:7233-7235.
46. Ambinder RF, Robertson KD, Tao Q. DNA methylation and the Epstein-Barr virus. Semin Cancer Biol. 1999;9:369-375.
47. Sutter D, Doerfler W. Methylation of integrated adenovirus type 12 DNA sequences in transformed cells is inversely correlated with viral gene expression. Proc Natl Acad Sci USA. 1980;77:253-256.
48. Yoder JA, Walsh CP, Bestor TH, Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 1997;13:335-340.
49. Doerfler W, Remus R, Muller K, et al. The fate of foreign DNA in mammalian cells and organisms. Dev Biol (Basel). 2001;106:89-97.
50. Jenuwein T, Forrester WC, Fernandez-Herrero LA, et al. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature. 1997;385:269-272.
51. Palefsky JM, Cutaneous and genital HPV-infected lesions in HIV-infected patients. Clin Dermatol. 1997;15:439-447.
52. Palefsky JM, Holly EA, Ralston ML, et al. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med. 1997;73:174-180.
53. Aynaud O, Piron D, Barrasso R, et al. Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects. Sex Transm Infect. 1998;74:32-34.
54. Eckert LO, Watts DH, Koutsky LA, et al. A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy. Infect Dis Obstet Gynecol. 1999;7:158-164.
55. O'Brien WA, Zack JA, Chen IS. Molecular pathogenesis of HIV-1, AIDS. 1990;4(Suppl 1):S41-S48.
56. Pantaleo G, Graziosi C, Fauci AS. New concepts in die immunopathogenesis of human immunodeficiency virus infection, N Engl J Med. 1993;328:327-335.
57. Minkoff H, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS. 2001;15:2157-2164.
58. Francis DA, Schmid SI, Howley PM. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J Virol. 2000;74:2679-2686.